Clinical Trial Update: Fenretinide in Treating Patients With Cervical Neoplasia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Fenretinide in treating cervical neoplasia, including cervical cancer and precancerous conditions; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Precancerous Cervical Neoplasia

Drugs mentioned

• Fenretinide (fenretinide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cervical Cancer, Precancerous Condition | Phase 3 | Status: COMPLETED